Ultragenyx Pharmaceutical Inc. (RARE) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-13 18:47:46 ET
Ultragenyx Pharmaceutical Inc. (RARE) Q4 2025 Earnings Call February 12, 2026 5:00 PM EST...
Read the full article on Seeking Alpha
For further details see:
Ultragenyx Pharmaceutical Inc. (RARE) Q4 2025 Earnings Call Transcript
Ultragenyx Pharmaceutical Inc.
NASDAQ: RARE
RARE Trading
-5.17% G/L:
$21.81 Last:
672,373 Volume:
$22.78 Open:
RARE Latest News
March 12, 2026 08:30:00 am
Ultragenyx Announces Positive 36-Week Data from Phase 3 Study of DTX301 AAV8 Gene Therapy for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency
RARE Stock Data
$2,352,123,132
91,171,303
0.09%
84
N/A
Biotechnology & Life Sciences
Healthcare
US
Novato
